Discovery about obesity drug helping scientists develop new cancer treatmentsJuly 09, 2007WINSTON-SALEM, N.C. - Based on their surprising discovery that an obesity drug can kill cancer cells, scientists at Wake Forest University School of Medicine have made a new finding about the drug's effects and are working to design more potent cancer treatments. Published online today in Nature Structural and Molecular Biology, the study is the first to report how the drug orlistat (Xenical® or Alli®) binds and interacts with a protein found in tumor cells. The drug blocks the protein's function and causes cell death. The project started five years ago when Steven Kridel, Ph.D., an assistant professor in the Department of Cancer Biology, analyzed prostate cancer cells to see which enzymes were expressed at high levels. His hope was that treatments to inhibit those enzymes could also stop tumor growth. "We found that a protein known as fatty acid synthase is expressed at high levels in prostate tumor cells, and is fairly absent in normal cells," said Kridel. Other research has shown that the protein is found in many tumor cells including breast, colon, ovarian, liver, lung and brain. "High levels of fatty acid synthase correlate with a poor prognosis so it is a great treatment target," said Kridel. "This makes an exciting treatment target because theoretically you don't have to worry about harming nearby healthy tissue." Unfortunately, orlistat itself cannot be used as a cancer treatment because, while it can kill cancer cells in the laboratory, in humans it is designed to act only in the digestive tract. "Understanding this drug-protein interaction is essential for designing new drugs," said W. Todd Lowther, Ph.D., an assistant professor in the Department of Biochemistry. "We've used a technique known as X-ray crystallography and now have a three-dimensional snapshot of the drug interacting with the protein." "Our goal is to develop an orlistat-like drug that can get into the bloodstream and go to the site of a tumor," said Lowther. Once they developed the three-dimensional map of the interaction, Lowther and Kridel began screening hundreds of thousands of compounds to identify those that interact with cancer cells in the same way as orlistat. They have narrowed the list of possibilities down to a dozen and will now work to optimize the compounds in hopes of creating potent cancer treatments. The drugs will first be tested in animals and then in human cancer patients. Fatty acid synthase is also found in fat cells, which suggests that if the scientists are successful in developing an anti-cancer drug, it could also be an effective obesity drug. "You might have the same drug for treating a cancer patient as an obese patient," said Lowther. Wake Forest University Baptist Medical Center |
|||||||||||||||||||||
| Related Cancer Cells Current Events and Cancer Cells News Articles Common pain relief medication may encourage cancer growth Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells. Cancers' Sweet Tooth May Be Weakness The pedal-to-the-metal signals driving the growth of several types of cancer cells lead to a common switch governing the use of glucose, researchers at Winship Cancer Institute of Emory University have discovered. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Paradoxical protein might prevent cancer One difficulty with fighting cancer cells is that they are similar in many respects to the body's stem cells. By focusing on the differences, researchers at Karolinska Institutet have found a new way of tackling colon cancer. The study is presented in the prestigious journal Cell. Cornell researchers identify a weak link in cancer cell armor The seeming invincibility of cancerous tumors may be crumbling, thanks to a promising new gene therapy that eliminates the ability of certain cells to repair themselves. Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities. Researchers 'notch' a victory toward new kind of cancer drug Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed. Barrow study identifies new way to biopsy brain tumors in real time A new miniature, hand-held microscope may allow more precise removal of brain tumors and an easier recognition of tumor locations during surgery. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Newly Discovered Fat Molecule: An Undersea Killer with an Upside A chemical culprit responsible for the rapid, mysterious death of phytoplankton in the North Atlantic Ocean has been found by collaborating scientists at Rutgers University and the Woods Hole Oceanographic Institution (WHOI). This same chemical may hold unexpected promise in cancer research. More Cancer Cells Current Events and Cancer Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||